INTERNATIONAL PATENT: SERMONIX PHARMACEUTICALS, INC. FILES APPLICATION FOR "LASOFOXIFENE TREATMENT OF ENDOCRINE THERAPY RESISTANT ER+ CANCER"

GENEVA, April 16 -- SERMONIX PHARMACEUTICALS, INC. (250 East Broad Street, Suite 250Columbus, OH 43215) filed a patent application (PCT/US2023/034706) for "LASOFOXIFENE TREATMENT OF ENDOCRINE THERAPY RESISTANT ER+ CANCER" on Oct 06, 2023. With publication no. WO/2025/075631, the details related to the patent application was published on Apr 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KOMM, Barry, Samuel (c/o Sermonix Pharmaceuticals, Inc.250 East Broad Street, Suite 250Columbus, OH 43215), GREENE, Geoffrey, L. (c/o Sermonix Pharmaceuticals, Inc.250 East Broad Street, Suite 250Columbi...